Article Details

Alnylam drug succeeds in key heart disease study, boosting company | BioPharma Dive

Retrieved on: 2022-08-03 11:44:28

Tags for this article:

Click the tags to see associated articles and topics

Alnylam drug succeeds in key heart disease study, boosting company | BioPharma Dive. View article details on hiswai:

Excerpt

An Alnylam Pharmaceuticals medicine helped patients with a deadly, genetic heart condition in a closely watched clinical trial, a finding that could ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up